Oncternal Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.5M | 2.9M | 0.54 |
| 2023-09-30 | $858k | 2.9M | 0.30 |
| 2023-06-30 | $987k | 2.9M | 0.35 |
| 2023-03-31 | $2.2M | 2.9M | 0.79 |
| 2022-12-31 | $2.9M | 2.9M | 1.00 |
| 2022-06-30 | $2.4M | 2.1M | 1.11 |
| 2022-03-31 | $3.2M | 2.3M | 1.39 |
| 2021-09-30 | $8.8M | 2.1M | 4.17 |
| 2021-06-30 | $10M | 2.1M | 4.75 |
| 2021-03-31 | $15M | 1.8M | 8.27 |
| 2020-12-31 | $8.1M | 1.7M | 4.84 |
| 2020-09-30 | $473k | 278k | 1.70 |
| 2020-06-30 | $808k | 285k | 2.84 |
| 2020-03-31 | $834k | 285k | 2.93 |
| 2019-12-31 | $1.1M | 285k | 3.95 |
| 2019-09-30 | $696k | 120k | 5.80 |